R-spondin-2



R-spondin-2

N1NN1R2RR2W3WW3R4RR4R5RR5N6NN6K7KK7R8RR8A9AA9S10SS10Y11YY11V12VV12S13SS13N14NN14P15PP15I16II16C17CC17K18KK18G19GG19C20CC20L21LL21S22SS22C23CC23S24SS24K25KK25D26DD26N27NN27G28GG28C29CC29S30SS30R31RR31C32CC32Q33QQ33Q34QQ34K35KK35L36LL36F37FF37F38FF38F39FF39L40LL40R41RR41R42RR42E43EE43G44GG44M45MM45R46RR46Q47QQ47... and 173 more residue(s)...... and 173 more residue(s)

SMILES None
InChIKey None
Sequence NRWRRNKRASYVSNPICKGCLSCSKDNGCSRCQQKLFFFLRREGMRQYGECLHSCPSGYYGHRAPDMNRCARCRIENCDSCFSKDFCTKCKVGFYLHRGRCFDECPDGFAPLDETMECVEGCEVGHWSEWGTCSRNNRTCGFKWGLETRTRQIVKKPAKDTIPCPTIAESRRCKMAMRHCPGGKRTPKAKEKRNKKKRRKLIERAQEQHSVFLATDRVNQ

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

R-spondin-2

N1NN1R2RR2W3WW3R4RR4R5RR5N6NN6K7KK7R8RR8A9AA9S10SS10Y11YY11V12VV12S13SS13N14NN14P15PP15I16II16C17CC17K18KK18G19GG19C20CC20L21LL21S22SS22C23CC23S24SS24K25KK25D26DD26N27NN27G28GG28C29CC29S30SS30R31RR31C32CC32Q33QQ33Q34QQ34K35KK35L36LL36F37FF37F38FF38F39FF39L40LL40R41RR41R42RR42E43EE43G44GG44M45MM45R46RR46Q47QQ47... and 173 more residue(s)...... and 173 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.